Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience-Reference-Cited by-同舟云学术

Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience

Published:2017-10-11 Issue:3 Volume:11 Page:337-341
ISSN:2048-8505
Container-title:Clinical Kidney Journal
language:en
Short-container-title:

Author:

Bagchi Soumita¹,Subbiah Arun Kumar¹,Bhowmik Dipankar¹,Mahajan Sandeep¹,Yadav Raj Kanwar¹,Kalaivani Mani²,Singh Geetika³,Dinda Amit³,Kumar Agarwal Sanjay¹

Affiliation:

1. Department of Nephrology, All India Institute of Medical Sciences, New Delhi, India

2. Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India

3. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ckj/article-pdf/11/3/337/25084710/sfx105.pdf

Reference24 articles.

1. Treatment of idiopathic membranous nephropathy;Hofstra;Nat Rev Nephrol,2013

2. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy;Polanco;J Am Soc Nephrol,2010

3. Long-term outcomes of persistent disease and relapse in primary membranous nephropathy;Kanigicherla;Nephrol Dial Transplant,2016

4. Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for glomerulonephritis;Kidney Disease;Kidney Int Suppl,2012

5. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy;Ponticelli;Kidney Int,1995

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel approaches to primary membranous nephropathy: Beyond the KDIGO guidelines;European Journal of Pharmacology;2024-11

2. Low Dose Rituximab and Calcineurin Inhibitor Combination as an Effective Treatment Strategy in Relapsed Primary Membranous Nephropathy;2024-05-30

3. Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?;Turkish Journal of Nephrology;2023-07-05

4. Immunosuppressive therapy for progressive idiopathic membranous nephropathy: a cost-effectiveness analysis in China;BMC Health Services Research;2023-04-12

5. The place of cyclical therapy for the treatment of membranous nephropathy in the era of rituximab;Clinical Kidney Journal;2023-04-10